John Daly, director of CareCloud, sold $19,350 at Investing.com

By CareCloud, Inc. (NASDAQ: CCLD ) director John Daly recently sold 5,000 shares of the company’s common stock, according to a filing with the Securities and Exchange Commission. The healthcare technology company, which is currently valued at approximately $59 million, has shown impressive performance with a 141% return over the past year. As he says Invest Pro Analytical, the stock is trading near its par value. In the year The transaction, which took place on December 31, 2024, was completed at a price of $3.87 per share, for a total value of $19,350. After this sale, Daly will own 61,750 shares in the company. Invest Pro Subscribers have 12 more key insights about CCLD, including a detailed analysis of its financial health, which is currently rated as great with an overall score of 3.16.

In other recent news, healthcare technology provider CareCloud was downgraded from Roth/MKM, from buy to neutral due to weak growth projections through 2025. Despite recent cost-cutting measures, the company’s growth outlook is not impressive, reducing revenue forecasts. That was third-quarter revenue of $28.5 million, which met analysts’ estimates, and the company’s adjusted EBTA increased to $6.8 million.

CareCloud’s third-quarter earnings report also showed a slight decline in revenue, falling to $28.5 million from $29.3 million last year. However, the company’s adjusted EBITDA increased significantly year-over-year to $6.8 million, and free cash flow improved significantly to $10.3 million.

The company has fully repaid the credit line and announced plans to resume dividend payments in March 2025. CareCloud also reported positive GAAP net income of $3.1 million in Q3 2023, up from a loss of $2.7 million. Direction.

This article was created by AI Support and reviewed by an editor. See our T&C for more information.